Stocks To Buy Now

Blog


Attend DGE’s 2nd Next-Gen MSL Excellence Summit

MSLs are critical in ensuring that products are used efficiently throughout their lifecycle. They serve as scientific peers and resources within the medical community, and provide valuable expertise to internal colleagues. MSLs, like the rest of the life science industry, must quickly adapt to the introduction of new technological platforms and rethink their workload in the post-COVID era. DGE will cordially welcome many professionals to attend the 2nd annual Next-Gen MSL Excellence Symposium, the only industry event dedicated to conquering the daily problems that this critical group faces while achieving career milestones and adjusting to new technology! This symposium is the only virtual industry event dedicated to the work problems encountered by MSLs, emphasizing the relevance of their role in drug and device development as well as adjusting to new technologies in the post-COVID era. Why Should You Attend It?
  • Strategies for outlining and achieving professional objectives
  • A guide for developing the leadership qualities to advance in your career path
  • Key methods for enhancing KOL engagements by honing communication and soft skills.
  • Techniques for collaborating well with cross-functional teams and participating in strategic planning
  • Innovative ways to use artificial intelligence and social media to gather information and impact medical policy
  • Learning and networking with field medical professionals and industry leaders in an interactive online platform
DGE’s 2nd Next-Gen MSL Excellence Symposium will provide a dynamic platform for medical industry KOLs and decision-makers to share their perspectives and discuss the role of MSLs in the changing landscape. They will also provide valuable tips and techniques for building a successful career and demonstrating the value of their skills to the company. This conference is also a fantastic chance for talented individuals interested in pursuing a successful MSL career. Medical Affairs personnel will contact teams that conduct similar duties in order to gain new and expanded ideas and roles. For more information, visit https://ibn.fm/aHMOd.

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Builds Momentum in Fight Against Rare, Chronic Cancer

February 2, 2026

Cutaneous T-cell lymphoma (“CTCL”) remains a cancer with limited treatment options, persistent symptoms and long-term quality-of-life challenges for patients, even decades after its classification as a distinct disease. Despite medical advances in oncology, many people living with CTCL continue to cycle through therapies that offer only partial relief or introduce new burdens. Soligenix (NASDAQ: SNGX) […]

Rotate your device 90° to view site.